Epidermal Growth Factor Receptor Transactivation Is Necessary for Glucagon-Like Peptide-1 to Protect PC12 Cells from Apoptosis

Publisher： Karger

E-ISSN： 1423-0194|97|4|300-308

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.97, Iss.4, 2012-12, pp. : 300-308

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional Insulin-Like Growth Factor-1/Insulin-Like Growth Factor-1 Receptor-Mediated Circuit in Human and Murine Thymic Epithelial Cells

By  

Neuroendocrinology, Vol. 75, Iss. 2, 2002-02 ,pp. : 139-150

Karger

Access to resources Recommend Favorite

Mechanisms Involved in Glucagon-Like Peptide-1 (7–36) Amide Action on the Rat Hypothalamo-Neurohypophysial System

By  

Neuroendocrinology, Vol. 77, Iss. 2, 2003-03 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 47-53

Karger

Access to resources Recommend Favorite

Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor

By  

Hormone Research in Paediatrics, Vol. 78, Iss. 1, 2012-07 ,pp. : 54-58

Karger

Access to resources Recommend Favorite

Effects of Glucagon-Like Peptide 1 (7–36 Amide) on Glucose Kinetics during Somatostatin-Induced Suppression of Insulin Secretion in Healthy Men

By  

Hormone Research in Paediatrics, Vol. 49, Iss. 5, 1998-04 ,pp. : 221-225

Karger

Access to resources Recommend Favorite